prednisolone has been researched along with alpha-Dystroglycanopathies in 1 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murakami, T | 1 |
| Sato, T | 1 |
| Adachi, M | 1 |
| Ishiguro, K | 1 |
| Shichiji, M | 1 |
| Tachimori, H | 1 |
| Nagata, S | 1 |
| Ishigaki, K | 1 |
1 other study available for prednisolone and alpha-Dystroglycanopathies
| Article | Year |
|---|---|
Efficacy of steroid therapy for Fukuyama congenital muscular dystrophy.
Topics: Administration, Oral; Cell Membrane; Child; Child, Preschool; Female; Homozygote; Humans; Male; Memb | 2021 |